Texas Oncology - Paris is a clinical research site located in Paris, Texas, United States 75460.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Texas Oncology - Paris has participated in 7 clinical trials with 3 currently active.
Therapeutic areas: Metastatic Breast Cancer, Cancer, Nonsmall Cell Lung Cancer.
Sponsors: Eli Lilly and Company, Tizona Therapeutics, Inc, NovoCure GmbH.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology - Paris has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology - Paris has 7 clinical trials on record, with 3 currently active. Their work covers Metastatic Breast Cancer, Cancer, Nonsmall Cell Lung Cancer.
Yes — Texas Oncology - Paris holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.